These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8227445)

  • 1. Effect of embolisation of meningioma on Ki-67 proliferation index.
    Paulus W; Meixensberger J; Hofmann E; Roggendorf W
    J Clin Pathol; 1993 Sep; 46(9):876-7. PubMed ID: 8227445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triple approach for diagnosis and grading of meningiomas: histology, morphometry of Ki-67/Feulgen stainings, and cytogenetics.
    Kolles H; Niedermayer I; Schmitt C; Henn W; Feld R; Steudel WI; Zang KD; Feiden W
    Acta Neurochir (Wien); 1995; 137(3-4):174-81. PubMed ID: 8789658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between Ki-67 labeling and mitotic index in gliomas and meningiomas: demonstration of the variability of the intermitotic cycle time.
    Schröder R; Bien K; Kott R; Meyers I; Vössing R
    Acta Neuropathol; 1991; 82(5):389-94. PubMed ID: 1767633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases.
    Roser F; Samii M; Ostertag H; Bellinzona M
    Acta Neurochir (Wien); 2004 Jan; 146(1):37-44; discussion 44. PubMed ID: 14740263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferation and DNA fragmentation in meningioma subtypes.
    Maier H; Wanschitz J; Sedivy R; Rössler K; Ofner D; Budka H
    Neuropathol Appl Neurobiol; 1997 Dec; 23(6):496-506. PubMed ID: 9460716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracranial meningeal tumours in childhood: a clinicopathologic study including MIB-1 immunohistochemistry.
    Demirtaş E; Erşahin Y; Yilmaz F; Mutluer S; Veral A
    Pathol Res Pract; 2000; 196(3):151-8. PubMed ID: 10729919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MIB1 staining index and scoring of histologic features in meningioma. Indicators for the prediction of biologic potential and postoperative management.
    Ohta M; Iwaki T; Kitamoto T; Takeshita I; Tateishi J; Fukui M
    Cancer; 1994 Dec; 74(12):3176-89. PubMed ID: 7982181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical detection of progesterone receptors and the correlation with Ki-67 labeling indices in paraffin-embedded sections of meningiomas.
    Nagashima G; Aoyagi M; Wakimoto H; Tamaki M; Ohno K; Hirakawa K
    Neurosurgery; 1995 Sep; 37(3):478-82; discussion 483. PubMed ID: 7501113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meningioangiomatosis. A clinicopathologic study including MIB1 immunoreactivity.
    Prayson RA
    Arch Pathol Lab Med; 1995 Nov; 119(11):1061-4. PubMed ID: 7487408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The significance of Ki-67/MIB-1 labeling index in human meningiomas: a literature study.
    Abry E; Thomassen IØ; Salvesen ØO; Torp SH
    Pathol Res Pract; 2010 Dec; 206(12):810-5. PubMed ID: 20951502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased proliferative activity due to necroses induced by pre-operative embolization in benign meningiomas.
    Patsouris E; Laas R; Hagel C; Stavrou D
    J Neurooncol; 1998 Dec; 40(3):257-64. PubMed ID: 10066099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative growth fraction evaluation with MIB1 and Ki67 antibodies in breast carcinomas.
    Barbareschi M; Girlando S; Mauri FM; Forti S; Eccher C; Mauri FA; Togni R; Dalla Palma P; Doglioni C
    Am J Clin Pathol; 1994 Aug; 102(2):171-5. PubMed ID: 8042584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative investigation of proliferation markers and their prognostic relevance in human meningiomas.
    Torp SH; Lindboe CF; Granli US; Moen TM; Nordtømme T
    Clin Neuropathol; 2001; 20(5):190-5. PubMed ID: 11594503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Which proliferation markers for routine immunohistology? A comparison of five antibodies.
    Rose DS; Maddox PH; Brown DC
    J Clin Pathol; 1994 Nov; 47(11):1010-4. PubMed ID: 7829674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of MIB-1 (Ki-67) antigen and bromodeoxyuridine proliferation indices in meningiomas.
    Langford LA; Cooksley CS; DeMonte F
    Hum Pathol; 1996 Apr; 27(4):350-4. PubMed ID: 8617477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MIB1 proliferation index in meningiomas: does it predict recurrence? A clinicopathological study.
    Tyagi A; Chakrabarty A; Franks A
    Br J Neurosurg; 2004 Aug; 18(4):357-61. PubMed ID: 15702834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation Between Digital and Manual Determinations of Ki-67/MIB-1 Proliferative Indices in Human Meningiomas.
    Pham DT; Skaland I; Winther TL; Salvesen Ø; Torp SH
    Int J Surg Pathol; 2020 May; 28(3):273-279. PubMed ID: 31771372
    [No Abstract]   [Full Text] [Related]  

  • 18. MIB-1 staining index and peritumoral brain edema of meningiomas.
    Ide M; Jimbo M; Yamamoto M; Umebara Y; Hagiwara S; Kubo O
    Cancer; 1996 Jul; 78(1):133-43. PubMed ID: 8646709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB1.
    McCormick D; Chong H; Hobbs C; Datta C; Hall PA
    Histopathology; 1993 Apr; 22(4):355-60. PubMed ID: 8514278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical expression of proliferating cell nuclear antigen (PCNA) in intracranial glioma and meningioma.
    Shih YH; Kadota Y; Sato K; Sueyoshi N; Shirai T
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 Apr; 53(4):193-7. PubMed ID: 7911730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.